Clinical Trial Update: Idiotypic Vaccination for Follicular Lymphoma Patients [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating an idiotypic vaccination strategy for patients with Follicular Lymphoma in first relapse or progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Idiotypic vaccination

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Follicular Lymphoma, First Relapse/Progression | Phase 2 | Status: UNKNOWN